Literature DB >> 53842

Oncornavirus-like particles released from arginine-deprived human lymphoblastoid cell lines.

M Kotler, H Balabanova, E Weinberg, A Friedmann, Y Becker.   

Abstract

Type-C RNA tumor virus particles were released from three different human lymphoblastoid cell lines after incubation in arginine-deficient medium. The released virus-like particles were characterized by (a) their ability to band in sucrose gradients at a density of 1.16-1.18 g/ml; (b) the presence of an RNA-directed DNA polymerase activity resembling that of the oncornaviruses; and (c) isolation of cores that band at a density of 1.26-1.27 g/ml in sucrose gradients. Examination of the arginine-deprived human lymphoblastoid cell line strain P3HR-1 by electron microscopy revealed the presence of C-type particles in the intracellular spaces.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53842      PMCID: PMC388769          DOI: 10.1073/pnas.72.11.4592

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.

Authors:  G E FOLEY; H LAZARUS; S FARBER; B G UZMAN; B A BOONE; R E MCCARTHY
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

2.  Viral-related information in oncornavirus-lik particles isolated from cultures of marrow cells from leukemic patients in relapse and remission.

Authors:  T W Mak; S Kurtz; J Manaster; D Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

3.  Simultaneous detection of reverse transcriptase and high molecular weight RNA unique to oncogenic RNA viruses.

Authors:  J Schlom; S Spiegelman
Journal:  Science       Date:  1971-11-19       Impact factor: 47.728

4.  Particles released from arginine deprived human leukaemic cells.

Authors:  M Kotler; E Weinberg; O Haspel; U Olshevsky; Y Becker
Journal:  Nat New Biol       Date:  1973-08-15

5.  Burkitt's tumors contain particles encapsulating RNA-instructed DNA polymerase and high molecular weight virus-related RNA.

Authors:  D Kufe; I T Magrath; J L Ziegler; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

6.  Reverse transcriptase activity of human acute leukaemic cells: purification of the enzyme, response to AMV 70S RNA, and characterization of the DNA product.

Authors:  M G Sarngadharan; P S Sarin; M S Reitz; R C Gallo
Journal:  Nat New Biol       Date:  1972-11-15

7.  Viral-related RNA in Hodgkins' disease and other human lymphomas.

Authors:  R Hehlmann; D Kufe; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

8.  Reverse transcriptase-containing particles induced in rous sarcoma virus-transformed rat cells by arginine deprivation.

Authors:  M Kotler; E Weinberg; O Haspel; Y Becker
Journal:  J Virol       Date:  1972-09       Impact factor: 5.103

9.  Leukemia-specific DNA sequences in leukocytes of the leukemic member of identical twins.

Authors:  W Baxt; J W Yates; H J Wallace; J F Holland; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

10.  Particles with characteristics of leukoviruses in cultures of marrow cells from leukemic patients in remission and relapse.

Authors:  T W Mak; J Manaster; A F Howatson; E A McCulloch; J E Till
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

View more
  3 in total

1.  Endogenous retroviruses in the human genome--a point of view.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

2.  Induction of murine p30 by superinfecting herpesviruses.

Authors:  C L Reed; F Rapp
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

3.  Retrovirus-like particles in EBV-negative Burkitt's lymphoma cell line but not in EBV-DNA-positive lines from patients with ataxia telangiectasia and Down's syndrome.

Authors:  M Kotler; H Balabanova; A Friedmann; Y Becker
Journal:  Br J Cancer       Date:  1979-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.